The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective.

Autor: Alroughani R; Division of Neurology, Department of Medicine, Al Amiri Hospital, Kuwait., Van Wijmeersch B; Universiteit Hasselt and Rehabilitation & MS-Centre Pelt, Belgium., Al Khaboori J; Khoula Hospital, Mina Al Fahal, Muscat, Oman., Alsharoqi IA; Salmaniya Medical Complex, Bahrain., Ahmed SF; Ibn Sina Hospital, Kuwait., Hassan A; Tawam Hospital, Al Ain, Abu Dhabi, United Arab Emirates., Inshasi J; Rashid Hospital, Dubai, United Arab Emirates., Krieger DW; Mediclinic Hospital, Dubai, United Arab Emirates., Shakra M; Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates., Shatila AO; Al Mafraq Hospital, Abu Dhabi, United Arab Emirates., Szolics M; Tawam Hospital, Al Ain, Abu Dhabi, United Arab Emirates., Khallaf M; Sanofi Genzyme, Dubai, United Arab Emirates., Ezzat A; Sanofi Genzyme, Dubai, United Arab Emirates.

Publikováno v: Therapeutic advances in neurological disorders [Ther Adv Neurol Disord] 2020 Sep 16; Vol. 13, pp. 1756286420954119. Date of Electronic Publication: 2020 Sep 16 (Print Publication: 2020).